Literature DB >> 31075771

The value of visible 5-ALA fluorescence and quantitative protoporphyrin IX analysis for improved surgery of suspected low-grade gliomas.

Georg Widhalm1,2, Jonathan Olson3, Jonathan Weller1, Jaime Bravo3, Seunggu J Han1,4, Joanna Phillips5, Shawn L Hervey-Jumper1, Susan M Chang1, David W Roberts3,6, Mitchel S Berger1.   

Abstract

OBJECTIVE: In patients with suspected diffusely infiltrating low-grade gliomas (LGG), the prognosis is dependent especially on extent of resection and precision of tissue sampling. Unfortunately, visible 5-aminolevulinic acid (5-ALA) fluorescence is usually only present in high-grade gliomas (HGGs), and most LGGs cannot be visualized. Recently, spectroscopic probes were introduced allowing in vivo quantitative analysis of intratumoral 5-ALA-induced protoporphyrin IX (PpIX) accumulation. The aim of this study was to intraoperatively investigate the value of visible 5-ALA fluorescence and quantitative PpIX analysis in suspected diffusely infiltrating LGG.
METHODS: Patients with radiologically suspected diffusely infiltrating LGG were prospectively recruited, and 5-ALA was preoperatively administered. During resection, visual fluorescence and absolute tissue PpIX concentration (CPpIX) measured by a spectroscopic handheld probe were determined in different intratumoral areas. Subsequently, corresponding tissue samples were safely collected for histopathological analysis. Tumor diagnosis was established according to the World Health Organization 2016 criteria. Additionally, the tumor grade and percentage of tumor cells were investigated in each sample.
RESULTS: All together, 69 samples were collected from 22 patients with histopathologically confirmed diffusely infiltrating glioma. Visible fluorescence was detected in focal areas in most HGGs (79%), but in none of the 8 LGGs. The mean CPpIX was significantly higher in fluorescing samples than in nonfluorescing samples (0.693 μg/ml and 0.008 μg/ml, respectively; p < 0.001). A significantly higher mean percentage of tumor cells was found in samples with visible fluorescence compared to samples with no fluorescence (62% and 34%, respectively; p = 0.005), and significant correlation of CPpIX and percentage of tumor cells was found (r = 0.362, p = 0.002). Moreover, high-grade histology was significantly more common in fluorescing samples than in nonfluorescing samples (p = 0.001), whereas no statistically significant difference in mean CPpIX was noted between HGG and LGG samples. Correlation between maximum CPpIX and overall tumor grade was highly significant (p = 0.005). Finally, 14 (40%) of 35 tumor samples with no visible fluorescence and 16 (50%) of 32 LGG samples showed significantly increased CPpIX (cutoff value: 0.005 μg/ml).
CONCLUSIONS: Visible 5-ALA fluorescence is able to detect focal intratumoral areas of malignant transformation, and additional quantitative PpIX analysis is especially useful to visualize mainly LGG tissue that usually remains undetected by conventional fluorescence. Thus, both techniques will support the neurosurgeon in achieving maximal safe resection and increased precision of tissue sampling during surgery for suspected LGG.Clinical trial registration no.: NCT01116661 (clinicaltrials.gov).

Entities:  

Keywords:  5-ALA = 5-aminolevulinic acid; CE = contrast enhancement; CPpIX = PpIX concentration; DTI = diffusion tensor imaging; HGG = high-grade glioma; IDH = isocitrate dehydrogenase; LGG = low-grade glioma; MRI = magnetic resonance imaging; NPV = negative predictive value; PPV = positive predictive value; PpIX = protoporphyrin IX; PpIX analysis; ROC = receiver operating characteristic; San Francisco; UCSF = University of California; WHO = World Health Organization; anaplastic foci; oncology; suspected LGG; tumor visualization; visible fluorescence

Year:  2019        PMID: 31075771      PMCID: PMC7184556          DOI: 10.3171/2019.1.JNS182614

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  37 in total

1.  Value of 1H-magnetic resonance spectroscopy chemical shift imaging for detection of anaplastic foci in diffusely infiltrating gliomas with non-significant contrast-enhancement.

Authors:  Georg Widhalm; Martin Krssak; Georgi Minchev; Adelheid Wöhrer; Tatjana Traub-Weidinger; Thomas Czech; Susanne Asenbaum; Christine Marosi; Engelbert Knosp; Johannes A Hainfellner; Daniela Prayer; Stefan Wolfsberger
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-10-22       Impact factor: 10.154

Review 2.  5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas.

Authors:  Muhammad Omar Chohan; Mitchel S Berger
Journal:  J Neurooncol       Date:  2018-08-10       Impact factor: 4.130

3.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

Authors:  Walter Stummer; Uwe Pichlmeier; Thomas Meinel; Otmar Dieter Wiestler; Friedhelm Zanella; Hans-Jürgen Reulen
Journal:  Lancet Oncol       Date:  2006-05       Impact factor: 41.316

Review 4.  European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas.

Authors:  Michael Weller; Martin van den Bent; Jörg C Tonn; Roger Stupp; Matthias Preusser; Elizabeth Cohen-Jonathan-Moyal; Roger Henriksson; Emilie Le Rhun; Carmen Balana; Olivier Chinot; Martin Bendszus; Jaap C Reijneveld; Frederick Dhermain; Pim French; Christine Marosi; Colin Watts; Ingela Oberg; Geoffrey Pilkington; Brigitta G Baumert; Martin J B Taphoorn; Monika Hegi; Manfred Westphal; Guido Reifenberger; Riccardo Soffietti; Wolfgang Wick
Journal:  Lancet Oncol       Date:  2017-05-05       Impact factor: 41.316

5.  Intratumoral histologic heterogeneity of gliomas. A quantitative study.

Authors:  W Paulus; J Peiffer
Journal:  Cancer       Date:  1989-07-15       Impact factor: 6.860

6.  Prognostic significance of imaging contrast enhancement for WHO grade II gliomas.

Authors:  Johan Pallud; Laurent Capelle; Luc Taillandier; Denys Fontaine; Emmanuel Mandonnet; Rémy Guillevin; Luc Bauchet; Philippe Peruzzi; Florence Laigle-Donadey; Michèle Kujas; Jacques Guyotat; Marie-Hélène Baron; Karima Mokhtari; Hugues Duffau
Journal:  Neuro Oncol       Date:  2008-08-12       Impact factor: 12.300

Review 7.  What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?

Authors:  Costas G Hadjipanayis; Georg Widhalm; Walter Stummer
Journal:  Neurosurgery       Date:  2015-11       Impact factor: 4.654

8.  Optical touch pointer for fluorescence guided glioblastoma resection using 5-aminolevulinic acid.

Authors:  Neda Haj-Hosseini; Johan Richter; Stefan Andersson-Engels; Karin Wårdell
Journal:  Lasers Surg Med       Date:  2010-01       Impact factor: 4.025

9.  5-Aminolevulinic acid induced fluorescence is a powerful intraoperative marker for precise histopathological grading of gliomas with non-significant contrast-enhancement.

Authors:  Georg Widhalm; Barbara Kiesel; Adelheid Woehrer; Tatjana Traub-Weidinger; Matthias Preusser; Christine Marosi; Daniela Prayer; Johannes A Hainfellner; Engelbert Knosp; Stefan Wolfsberger
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

10.  The Value of 5-Aminolevulinic Acid in Low-grade Gliomas and High-grade Gliomas Lacking Glioblastoma Imaging Features: An Analysis Based on Fluorescence, Magnetic Resonance Imaging, 18F-Fluoroethyl Tyrosine Positron Emission Tomography, and Tumor Molecular Factors.

Authors:  Mohammed Jaber; Johannes Wölfer; Christian Ewelt; Markus Holling; Martin Hasselblatt; Thomas Niederstadt; Tarek Zoubi; Matthias Weckesser; Walter Stummer
Journal:  Neurosurgery       Date:  2016-03       Impact factor: 4.654

View more
  18 in total

1.  Fluorescence Image-Guided Surgery - a Perspective on Contrast Agent Development.

Authors:  Connor W Barth; Summer L Gibbs
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2020-02-19

2.  Heme Biosynthesis Factors and 5-ALA Induced Fluorescence: Analysis of mRNA and Protein Expression in Fluorescing and Non-fluorescing Gliomas.

Authors:  Mario Mischkulnig; Thomas Roetzer-Pejrimovsky; Daniela Lötsch-Gojo; Nina Kastner; Katharina Bruckner; Romana Prihoda; Alexandra Lang; Mauricio Martinez-Moreno; Julia Furtner; Anna Berghoff; Adelheid Woehrer; Walter Berger; Georg Widhalm; Barbara Kiesel
Journal:  Front Med (Lausanne)       Date:  2022-05-18

3.  Towards real-time wide-field fluorescence lifetime imaging of 5-ALA labeled brain tumors with multi-tap CMOS cameras.

Authors:  David Reichert; Mikael T Erkkilä; Gerhard Holst; Nancy Hecker-Denschlag; Marco Wilzbach; Christoph Hauger; Wolfgang Drexler; Johanna Gesperger; Barbara Kiesel; Thomas Roetzer; Angelika Unterhuber; Georg Widhalm; Rainer A Leitgeb; Marco Andreana
Journal:  Biomed Opt Express       Date:  2020-02-26       Impact factor: 3.732

Review 4.  Fluorescence Guidance and Intraoperative Adjuvants to Maximize Extent of Resection.

Authors:  Cordelia Orillac; Walter Stummer; Daniel A Orringer
Journal:  Neurosurgery       Date:  2021-10-13       Impact factor: 4.654

5.  Macroscopic fluorescence-lifetime imaging of NADH and protoporphyrin IX improves the detection and grading of 5-aminolevulinic acid-stained brain tumors.

Authors:  Mikael T Erkkilä; David Reichert; Johanna Gesperger; Barbara Kiesel; Thomas Roetzer; Petra A Mercea; Wolfgang Drexler; Angelika Unterhuber; Rainer A Leitgeb; Adelheid Woehrer; Angelika Rueck; Marco Andreana; Georg Widhalm
Journal:  Sci Rep       Date:  2020-11-24       Impact factor: 4.379

6.  TCGA mRNA Expression Analysis of the Heme Biosynthesis Pathway in Diffusely Infiltrating Gliomas: A Comparison of Typically 5-ALA Fluorescent and Non-Fluorescent Gliomas.

Authors:  Mario Mischkulnig; Barbara Kiesel; Daniela Lötsch; Thomas Roetzer; Martin Borkovec; Lisa I Wadiura; Petra A Mercea; Florian J Jaklin; Shawn Hervey-Jumper; Karl Roessler; Mitchel S Berger; Georg Widhalm; Friedrich Erhart
Journal:  Cancers (Basel)       Date:  2020-07-24       Impact factor: 6.639

Review 7.  Molecular and Metabolic Mechanisms Underlying Selective 5-Aminolevulinic Acid-Induced Fluorescence in Gliomas.

Authors:  Jeffrey I Traylor; Mark N Pernik; Alex C Sternisha; Samuel K McBrayer; Kalil G Abdullah
Journal:  Cancers (Basel)       Date:  2021-02-02       Impact factor: 6.639

Review 8.  Fluorescence-Guided Surgery for High-Grade Gliomas: State of the Art and New Perspectives.

Authors:  Giuseppe Palmieri; Fabio Cofano; Luca Francesco Salvati; Matteo Monticelli; Pietro Zeppa; Giuseppe Di Perna; Antonio Melcarne; Roberto Altieri; Giuseppe La Rocca; Giovanni Sabatino; Giuseppe Maria Barbagallo; Fulvio Tartara; Francesco Zenga; Diego Garbossa
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

9.  BOLD asynchrony elucidates tumor burden in IDH-mutated gliomas.

Authors:  Petros D Petridis; Craig I Horenstein; Brianna Pereira; Peter B Wu; Jorge Samanamud; Tamara Marie; Deborah Boyett; Tejaswi D Sudhakar; Sameer A Sheth; Guy M McKhann; Michael B Sisti; Jeffrey N Bruce; Peter Canoll; Jack Grinband
Journal:  Neuro Oncol       Date:  2022-01-05       Impact factor: 13.029

10.  High Interobserver Agreement in the Subjective Classification of 5-Aminolevulinic Acid Fluorescence Levels in Newly Diagnosed Glioblastomas.

Authors:  Mario Mischkulnig; Barbara Kiesel; Martin Borkovec; Lisa I Wadiura; Dimitri Benner; Arthur Hosmann; Shawn Hervey-Jumper; Engelbert Knosp; Karl Roessler; Mitchel S Berger; Georg Widhalm
Journal:  Lasers Surg Med       Date:  2020-03-08       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.